TABLE 1.
Virus | Main conclusions | [Ref.] |
HHV | EBV detected in serum of 12 out of 13 subjects with IPF but not in patients with other forms of ILD | [22] |
MHV-68 triggers an exaggerated fibrotic response in mice | [23] | |
Increased incidence of EBV in BAL and lung biopsies of IPF subjects compared to controls | [24, 25] | |
EBV detected in BAL of two out of 43 AE-IPF subjects | [26] | |
CMV detected in BAL of two out of 43 AE-IPF subjects | [27] | |
A total of 38% of AE-IPF subjects exhibited evidence of CMV infection | [28] | |
HHV detected in nasopharyngeal swabs of 15 out of 30 AE-IPF subjects and four out of 30 individuals with stable IPF | [29] | |
TTV | TTV detected in BAL of 12 out of 43 AE-IPF subjects | [26] |
No evidence of TTV in BAL of stable IPF subjects | [30] | |
Increased mortality in IPF subjects with presence of TTV-DNA in serum compared to IPF subjects with no TTV-DNA | ||
Influenza A | Influenza A detected in nasopharyngeal swabs of 12 out of 30 AE-IPF subjects but not in individuals with stable IPF | [29] |
A case of AE-IPF was reported following pandemic influenza A vaccination | [31] |
HHV: human herpes virus; TTV: torque teno virus; EBV: Epstein–Barr virus; ILD: interstitial lung disease; MHV-68: murine γherpes virus-68; BAL: bronchoalveolar lavage; AE-IPF: acute exacerbation of IPF; CMV: cytomegalovirus.